Valo Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Helsinki
Industry:BiotechHealth services
Business model:B2B
Valo Therapeutics (Valo Tx) is a developer of a novel cancer immunotherapy based on an oncolytic virus non-covalently combined with tumor-specific peptides, delivers a highly immunogenic and unique tumor vaccination platform.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 27.28M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Valo Therapeutics
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
53%
|
|
![]() |
Acesion Pharma
53%
|
|
![]() |
Achilles Therapeutics
53%
|
|
![]() |
Antag Therapeutics
53%
|
|
![]() |
Aprea Therapeutics
53%
|
|
![]() |
Arthex Biotech S.L.
53%
|
|
![]() |
Atai Life Sciences
53%
|
|
![]() |
Biofidelity
53%
|
|
![]() |
BoneSupport
53%
|
|
![]() |
CatalYm
53%
|
|